nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—CYP3A4—Estropipate—osteoporosis	0.104	0.181	CbGbCtD
Pyridostigmine—CYP3A4—Calcitriol—osteoporosis	0.104	0.181	CbGbCtD
Pyridostigmine—CYP3A4—Ergocalciferol—osteoporosis	0.0833	0.145	CbGbCtD
Pyridostigmine—CYP3A4—Raloxifene—osteoporosis	0.0695	0.121	CbGbCtD
Pyridostigmine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0671	0.117	CbGbCtD
Pyridostigmine—CYP3A4—Cholecalciferol—osteoporosis	0.0537	0.0934	CbGbCtD
Pyridostigmine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0493	0.0858	CbGbCtD
Pyridostigmine—CYP3A4—Estradiol—osteoporosis	0.0433	0.0753	CbGbCtD
Pyridostigmine—Alopecia—Ibandronate—osteoporosis	0.00127	0.00305	CcSEcCtD
Pyridostigmine—Flatulence—Alendronate—osteoporosis	0.00126	0.00304	CcSEcCtD
Pyridostigmine—Muscle spasms—Estropipate—osteoporosis	0.00125	0.00301	CcSEcCtD
Pyridostigmine—Sweating increased—Zoledronate—osteoporosis	0.00125	0.003	CcSEcCtD
Pyridostigmine—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00124	0.00299	CcSEcCtD
Pyridostigmine—Flatulence—Raloxifene—osteoporosis	0.00124	0.00299	CcSEcCtD
Pyridostigmine—Confusional state—Etidronic acid—osteoporosis	0.00124	0.00298	CcSEcCtD
Pyridostigmine—Asthma—Conjugated Estrogens—osteoporosis	0.00123	0.00297	CcSEcCtD
Pyridostigmine—Muscle spasms—Alendronate—osteoporosis	0.00123	0.00297	CcSEcCtD
Pyridostigmine—Flatulence—Ibandronate—osteoporosis	0.00123	0.00296	CcSEcCtD
Pyridostigmine—Muscle spasms—Raloxifene—osteoporosis	0.00121	0.00292	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Ethinyl Estradiol—osteoporosis	0.0012	0.0029	CcSEcCtD
Pyridostigmine—Sweating increased—Conjugated Estrogens—osteoporosis	0.0012	0.00289	CcSEcCtD
Pyridostigmine—Muscle spasms—Ibandronate—osteoporosis	0.0012	0.00289	CcSEcCtD
Pyridostigmine—Vomiting—Calcium Acetate—osteoporosis	0.00119	0.00286	CcSEcCtD
Pyridostigmine—Bronchitis—Conjugated Estrogens—osteoporosis	0.00119	0.00286	CcSEcCtD
Pyridostigmine—Asthenia—Ergocalciferol—osteoporosis	0.00118	0.00285	CcSEcCtD
Pyridostigmine—Pollakiuria—Zoledronate—osteoporosis	0.00118	0.00285	CcSEcCtD
Pyridostigmine—Vertigo—Estropipate—osteoporosis	0.00117	0.00281	CcSEcCtD
Pyridostigmine—Lethargy—Estradiol—osteoporosis	0.00117	0.00281	CcSEcCtD
Pyridostigmine—Vertigo—Alendronate—osteoporosis	0.00115	0.00277	CcSEcCtD
Pyridostigmine—Vertigo—Raloxifene—osteoporosis	0.00113	0.00273	CcSEcCtD
Pyridostigmine—Agitation—Calcitriol—osteoporosis	0.00112	0.0027	CcSEcCtD
Pyridostigmine—Vertigo—Ibandronate—osteoporosis	0.00112	0.0027	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00112	0.00269	CcSEcCtD
Pyridostigmine—Nausea—Calcium Acetate—osteoporosis	0.00111	0.00267	CcSEcCtD
Pyridostigmine—Loss of consciousness—Raloxifene—osteoporosis	0.00111	0.00267	CcSEcCtD
Pyridostigmine—Myalgia—Estropipate—osteoporosis	0.00111	0.00267	CcSEcCtD
Pyridostigmine—Paraesthesia—Etidronic acid—osteoporosis	0.0011	0.00265	CcSEcCtD
Pyridostigmine—Myalgia—Alendronate—osteoporosis	0.00109	0.00263	CcSEcCtD
Pyridostigmine—Myalgia—Raloxifene—osteoporosis	0.00107	0.00258	CcSEcCtD
Pyridostigmine—Alopecia—Ethinyl Estradiol—osteoporosis	0.00107	0.00258	CcSEcCtD
Pyridostigmine—Myalgia—Ibandronate—osteoporosis	0.00106	0.00256	CcSEcCtD
Pyridostigmine—Convulsion—Calcitriol—osteoporosis	0.00106	0.00255	CcSEcCtD
Pyridostigmine—Dry skin—Estradiol—osteoporosis	0.00105	0.00252	CcSEcCtD
Pyridostigmine—Bradycardia—Zoledronate—osteoporosis	0.00104	0.00251	CcSEcCtD
Pyridostigmine—Myalgia—Calcitriol—osteoporosis	0.00104	0.0025	CcSEcCtD
Pyridostigmine—Cramp muscle—Estradiol—osteoporosis	0.00103	0.00248	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Zoledronate—osteoporosis	0.00102	0.00246	CcSEcCtD
Pyridostigmine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00101	0.00244	CcSEcCtD
Pyridostigmine—Flatulence—Risedronate—osteoporosis	0.00101	0.00244	CcSEcCtD
Pyridostigmine—Feeling abnormal—Etidronic acid—osteoporosis	0.00101	0.00243	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.001	0.00242	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Raloxifene—osteoporosis	0.000994	0.00239	CcSEcCtD
Pyridostigmine—Abdominal distension—Estradiol—osteoporosis	0.000993	0.00239	CcSEcCtD
Pyridostigmine—Alopecia—Pamidronate—osteoporosis	0.000992	0.00239	CcSEcCtD
Pyridostigmine—Muscle spasms—Risedronate—osteoporosis	0.000988	0.00238	CcSEcCtD
Pyridostigmine—Asthma—Estradiol—osteoporosis	0.000987	0.00238	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Ibandronate—osteoporosis	0.000984	0.00237	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.000982	0.00237	CcSEcCtD
Pyridostigmine—Nausea—Ergocalciferol—osteoporosis	0.00098	0.00236	CcSEcCtD
Pyridostigmine—Urticaria—Etidronic acid—osteoporosis	0.000974	0.00235	CcSEcCtD
Pyridostigmine—Abdominal pain—Etidronic acid—osteoporosis	0.00097	0.00234	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000967	0.00233	CcSEcCtD
Pyridostigmine—Sweating increased—Estradiol—osteoporosis	0.000961	0.00232	CcSEcCtD
Pyridostigmine—Paraesthesia—Estropipate—osteoporosis	0.000953	0.00229	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000952	0.00229	CcSEcCtD
Pyridostigmine—Bronchitis—Estradiol—osteoporosis	0.000949	0.00229	CcSEcCtD
Pyridostigmine—Somnolence—Estropipate—osteoporosis	0.000943	0.00227	CcSEcCtD
Pyridostigmine—Muscle spasms—Pamidronate—osteoporosis	0.000939	0.00226	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000936	0.00226	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000927	0.00223	CcSEcCtD
Pyridostigmine—Vertigo—Risedronate—osteoporosis	0.000923	0.00222	CcSEcCtD
Pyridostigmine—Paraesthesia—Ibandronate—osteoporosis	0.000914	0.0022	CcSEcCtD
Pyridostigmine—Pollakiuria—Estradiol—osteoporosis	0.000912	0.0022	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000908	0.00219	CcSEcCtD
Pyridostigmine—Alopecia—Zoledronate—osteoporosis	0.000906	0.00218	CcSEcCtD
Pyridostigmine—Hypersensitivity—Etidronic acid—osteoporosis	0.000904	0.00218	CcSEcCtD
Pyridostigmine—Loss of consciousness—Risedronate—osteoporosis	0.000903	0.00218	CcSEcCtD
Pyridostigmine—Agitation—Pamidronate—osteoporosis	0.000898	0.00216	CcSEcCtD
Pyridostigmine—Somnolence—Calcitriol—osteoporosis	0.000886	0.00213	CcSEcCtD
Pyridostigmine—Myalgia—Risedronate—osteoporosis	0.000875	0.00211	CcSEcCtD
Pyridostigmine—Alopecia—Conjugated Estrogens—osteoporosis	0.000872	0.0021	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Estropipate—osteoporosis	0.000868	0.00209	CcSEcCtD
Pyridostigmine—Feeling abnormal—Alendronate—osteoporosis	0.000861	0.00207	CcSEcCtD
Pyridostigmine—Loss of consciousness—Pamidronate—osteoporosis	0.000858	0.00207	CcSEcCtD
Pyridostigmine—Muscle spasms—Zoledronate—osteoporosis	0.000858	0.00207	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Alendronate—osteoporosis	0.000855	0.00206	CcSEcCtD
Pyridostigmine—Flatulence—Conjugated Estrogens—osteoporosis	0.000847	0.00204	CcSEcCtD
Pyridostigmine—Convulsion—Pamidronate—osteoporosis	0.000846	0.00204	CcSEcCtD
Pyridostigmine—Urticaria—Estropipate—osteoporosis	0.000843	0.00203	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00084	0.00202	CcSEcCtD
Pyridostigmine—Diarrhoea—Etidronic acid—osteoporosis	0.000839	0.00202	CcSEcCtD
Pyridostigmine—Abdominal pain—Estropipate—osteoporosis	0.000839	0.00202	CcSEcCtD
Pyridostigmine—Feeling abnormal—Ibandronate—osteoporosis	0.000839	0.00202	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000832	0.002	CcSEcCtD
Pyridostigmine—Myalgia—Pamidronate—osteoporosis	0.000832	0.002	CcSEcCtD
Pyridostigmine—Urticaria—Alendronate—osteoporosis	0.00083	0.002	CcSEcCtD
Pyridostigmine—Epistaxis—Estradiol—osteoporosis	0.00083	0.002	CcSEcCtD
Pyridostigmine—Abdominal pain—Alendronate—osteoporosis	0.000826	0.00199	CcSEcCtD
Pyridostigmine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000826	0.00199	CcSEcCtD
Pyridostigmine—Agitation—Zoledronate—osteoporosis	0.00082	0.00197	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000815	0.00196	CcSEcCtD
Pyridostigmine—Abdominal pain—Raloxifene—osteoporosis	0.000813	0.00196	CcSEcCtD
Pyridostigmine—Urticaria—Ibandronate—osteoporosis	0.000808	0.00195	CcSEcCtD
Pyridostigmine—Abdominal pain—Ibandronate—osteoporosis	0.000804	0.00194	CcSEcCtD
Pyridostigmine—Confusional state—Pamidronate—osteoporosis	0.000804	0.00194	CcSEcCtD
Pyridostigmine—Vertigo—Zoledronate—osteoporosis	0.000802	0.00193	CcSEcCtD
Pyridostigmine—Urticaria—Calcitriol—osteoporosis	0.000791	0.00191	CcSEcCtD
Pyridostigmine—Abdominal pain—Calcitriol—osteoporosis	0.000787	0.0019	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Estradiol—osteoporosis	0.000786	0.00189	CcSEcCtD
Pyridostigmine—Loss of consciousness—Zoledronate—osteoporosis	0.000784	0.00189	CcSEcCtD
Pyridostigmine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000783	0.0765	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Estropipate—osteoporosis	0.000782	0.00188	CcSEcCtD
Pyridostigmine—Vomiting—Etidronic acid—osteoporosis	0.00078	0.00188	CcSEcCtD
Pyridostigmine—Rash—Etidronic acid—osteoporosis	0.000773	0.00186	CcSEcCtD
Pyridostigmine—Convulsion—Zoledronate—osteoporosis	0.000773	0.00186	CcSEcCtD
Pyridostigmine—Dermatitis—Etidronic acid—osteoporosis	0.000773	0.00186	CcSEcCtD
Pyridostigmine—Vertigo—Conjugated Estrogens—osteoporosis	0.000772	0.00186	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Pamidronate—osteoporosis	0.000771	0.00186	CcSEcCtD
Pyridostigmine—Hypersensitivity—Alendronate—osteoporosis	0.00077	0.00185	CcSEcCtD
Pyridostigmine—Headache—Etidronic acid—osteoporosis	0.000768	0.00185	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000764	0.00184	CcSEcCtD
Pyridostigmine—Asthenia—Estropipate—osteoporosis	0.000761	0.00183	CcSEcCtD
Pyridostigmine—Myalgia—Zoledronate—osteoporosis	0.00076	0.00183	CcSEcCtD
Pyridostigmine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000755	0.00182	CcSEcCtD
Pyridostigmine—Paraesthesia—Risedronate—osteoporosis	0.000753	0.00181	CcSEcCtD
Pyridostigmine—Asthenia—Alendronate—osteoporosis	0.00075	0.00181	CcSEcCtD
Pyridostigmine—Hypersensitivity—Ibandronate—osteoporosis	0.00075	0.00181	CcSEcCtD
Pyridostigmine—Hypotension—Pamidronate—osteoporosis	0.000745	0.00179	CcSEcCtD
Pyridostigmine—Convulsion—Conjugated Estrogens—osteoporosis	0.000744	0.00179	CcSEcCtD
Pyridostigmine—Confusional state—Zoledronate—osteoporosis	0.000734	0.00177	CcSEcCtD
Pyridostigmine—Hypersensitivity—Calcitriol—osteoporosis	0.000734	0.00177	CcSEcCtD
Pyridostigmine—Myalgia—Conjugated Estrogens—osteoporosis	0.000731	0.00176	CcSEcCtD
Pyridostigmine—Asthenia—Ibandronate—osteoporosis	0.00073	0.00176	CcSEcCtD
Pyridostigmine—Nausea—Etidronic acid—osteoporosis	0.000729	0.00175	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000726	0.00175	CcSEcCtD
Pyridostigmine—Diarrhoea—Estropipate—osteoporosis	0.000726	0.00175	CcSEcCtD
Pyridostigmine—Paraesthesia—Pamidronate—osteoporosis	0.000716	0.00172	CcSEcCtD
Pyridostigmine—Diarrhoea—Alendronate—osteoporosis	0.000715	0.00172	CcSEcCtD
Pyridostigmine—Asthenia—Calcitriol—osteoporosis	0.000715	0.00172	CcSEcCtD
Pyridostigmine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000709	0.00171	CcSEcCtD
Pyridostigmine—Somnolence—Pamidronate—osteoporosis	0.000709	0.00171	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Zoledronate—osteoporosis	0.000704	0.0017	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000703	0.00169	CcSEcCtD
Pyridostigmine—Diarrhoea—Raloxifene—osteoporosis	0.000703	0.00169	CcSEcCtD
Pyridostigmine—Alopecia—Estradiol—osteoporosis	0.000698	0.00168	CcSEcCtD
Pyridostigmine—Diarrhoea—Ibandronate—osteoporosis	0.000696	0.00168	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Risedronate—osteoporosis	0.000686	0.00165	CcSEcCtD
Pyridostigmine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000683	0.00165	CcSEcCtD
Pyridostigmine—Diarrhoea—Calcitriol—osteoporosis	0.000682	0.00164	CcSEcCtD
Pyridostigmine—Hypotension—Zoledronate—osteoporosis	0.00068	0.00164	CcSEcCtD
Pyridostigmine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00068	0.00164	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000678	0.00163	CcSEcCtD
Pyridostigmine—Flatulence—Estradiol—osteoporosis	0.000678	0.00163	CcSEcCtD
Pyridostigmine—Vomiting—Estropipate—osteoporosis	0.000675	0.00163	CcSEcCtD
Pyridostigmine—Rash—Estropipate—osteoporosis	0.000669	0.00161	CcSEcCtD
Pyridostigmine—Dermatitis—Estropipate—osteoporosis	0.000668	0.00161	CcSEcCtD
Pyridostigmine—Urticaria—Risedronate—osteoporosis	0.000666	0.0016	CcSEcCtD
Pyridostigmine—Headache—Estropipate—osteoporosis	0.000665	0.0016	CcSEcCtD
Pyridostigmine—Vomiting—Alendronate—osteoporosis	0.000665	0.0016	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000663	0.0016	CcSEcCtD
Pyridostigmine—Abdominal pain—Risedronate—osteoporosis	0.000663	0.0016	CcSEcCtD
Pyridostigmine—Muscle spasms—Estradiol—osteoporosis	0.000661	0.00159	CcSEcCtD
Pyridostigmine—Rash—Alendronate—osteoporosis	0.000659	0.00159	CcSEcCtD
Pyridostigmine—Dermatitis—Alendronate—osteoporosis	0.000658	0.00159	CcSEcCtD
Pyridostigmine—Feeling abnormal—Pamidronate—osteoporosis	0.000657	0.00158	CcSEcCtD
Pyridostigmine—Hypotension—Conjugated Estrogens—osteoporosis	0.000655	0.00158	CcSEcCtD
Pyridostigmine—Headache—Alendronate—osteoporosis	0.000655	0.00158	CcSEcCtD
Pyridostigmine—Paraesthesia—Zoledronate—osteoporosis	0.000654	0.00157	CcSEcCtD
Pyridostigmine—Vomiting—Raloxifene—osteoporosis	0.000654	0.00157	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000652	0.00157	CcSEcCtD
Pyridostigmine—Rash—Raloxifene—osteoporosis	0.000648	0.00156	CcSEcCtD
Pyridostigmine—Dermatitis—Raloxifene—osteoporosis	0.000647	0.00156	CcSEcCtD
Pyridostigmine—Somnolence—Zoledronate—osteoporosis	0.000647	0.00156	CcSEcCtD
Pyridostigmine—Vomiting—Ibandronate—osteoporosis	0.000647	0.00156	CcSEcCtD
Pyridostigmine—Headache—Raloxifene—osteoporosis	0.000644	0.00155	CcSEcCtD
Pyridostigmine—Rash—Ibandronate—osteoporosis	0.000642	0.00155	CcSEcCtD
Pyridostigmine—Dermatitis—Ibandronate—osteoporosis	0.000641	0.00154	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000639	0.00154	CcSEcCtD
Pyridostigmine—Headache—Ibandronate—osteoporosis	0.000637	0.00154	CcSEcCtD
Pyridostigmine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000634	0.00153	CcSEcCtD
Pyridostigmine—Vomiting—Calcitriol—osteoporosis	0.000633	0.00153	CcSEcCtD
Pyridostigmine—Agitation—Estradiol—osteoporosis	0.000632	0.00152	CcSEcCtD
Pyridostigmine—Nausea—Estropipate—osteoporosis	0.00063	0.00152	CcSEcCtD
Pyridostigmine—Abdominal pain—Pamidronate—osteoporosis	0.00063	0.00152	CcSEcCtD
Pyridostigmine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00063	0.00152	CcSEcCtD
Pyridostigmine—Rash—Calcitriol—osteoporosis	0.000628	0.00151	CcSEcCtD
Pyridostigmine—Dermatitis—Calcitriol—osteoporosis	0.000627	0.00151	CcSEcCtD
Pyridostigmine—Headache—Calcitriol—osteoporosis	0.000624	0.0015	CcSEcCtD
Pyridostigmine—Somnolence—Conjugated Estrogens—osteoporosis	0.000623	0.0015	CcSEcCtD
Pyridostigmine—Nausea—Alendronate—osteoporosis	0.000621	0.0015	CcSEcCtD
Pyridostigmine—Hypersensitivity—Risedronate—osteoporosis	0.000618	0.00149	CcSEcCtD
Pyridostigmine—Vertigo—Estradiol—osteoporosis	0.000618	0.00149	CcSEcCtD
Pyridostigmine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000617	0.00149	CcSEcCtD
Pyridostigmine—Nausea—Raloxifene—osteoporosis	0.000611	0.00147	CcSEcCtD
Pyridostigmine—Nausea—Ibandronate—osteoporosis	0.000604	0.00146	CcSEcCtD
Pyridostigmine—Loss of consciousness—Estradiol—osteoporosis	0.000604	0.00146	CcSEcCtD
Pyridostigmine—Asthenia—Risedronate—osteoporosis	0.000602	0.00145	CcSEcCtD
Pyridostigmine—Feeling abnormal—Zoledronate—osteoporosis	0.0006	0.00145	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000595	0.00143	CcSEcCtD
Pyridostigmine—Nausea—Calcitriol—osteoporosis	0.000592	0.00143	CcSEcCtD
Pyridostigmine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000588	0.00142	CcSEcCtD
Pyridostigmine—Hypersensitivity—Pamidronate—osteoporosis	0.000587	0.00141	CcSEcCtD
Pyridostigmine—Myalgia—Estradiol—osteoporosis	0.000585	0.00141	CcSEcCtD
Pyridostigmine—Urticaria—Zoledronate—osteoporosis	0.000578	0.00139	CcSEcCtD
Pyridostigmine—Abdominal pain—Zoledronate—osteoporosis	0.000576	0.00139	CcSEcCtD
Pyridostigmine—Diarrhoea—Risedronate—osteoporosis	0.000574	0.00138	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000573	0.00138	CcSEcCtD
Pyridostigmine—Asthenia—Pamidronate—osteoporosis	0.000572	0.00138	CcSEcCtD
Pyridostigmine—Confusional state—Estradiol—osteoporosis	0.000566	0.00136	CcSEcCtD
Pyridostigmine—Urticaria—Conjugated Estrogens—osteoporosis	0.000557	0.00134	CcSEcCtD
Pyridostigmine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000554	0.00134	CcSEcCtD
Pyridostigmine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000547	0.00132	CcSEcCtD
Pyridostigmine—Diarrhoea—Pamidronate—osteoporosis	0.000545	0.00131	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Estradiol—osteoporosis	0.000542	0.00131	CcSEcCtD
Pyridostigmine—Rash—Ethinyl Estradiol—osteoporosis	0.000542	0.00131	CcSEcCtD
Pyridostigmine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000542	0.0013	CcSEcCtD
Pyridostigmine—Headache—Ethinyl Estradiol—osteoporosis	0.000539	0.0013	CcSEcCtD
Pyridostigmine—Hypersensitivity—Zoledronate—osteoporosis	0.000536	0.00129	CcSEcCtD
Pyridostigmine—Vomiting—Risedronate—osteoporosis	0.000533	0.00128	CcSEcCtD
Pyridostigmine—Rash—Risedronate—osteoporosis	0.000529	0.00127	CcSEcCtD
Pyridostigmine—Dermatitis—Risedronate—osteoporosis	0.000528	0.00127	CcSEcCtD
Pyridostigmine—Headache—Risedronate—osteoporosis	0.000525	0.00127	CcSEcCtD
Pyridostigmine—Asthenia—Zoledronate—osteoporosis	0.000522	0.00126	CcSEcCtD
Pyridostigmine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000517	0.00124	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000511	0.00123	CcSEcCtD
Pyridostigmine—Nausea—Ethinyl Estradiol—osteoporosis	0.000511	0.00123	CcSEcCtD
Pyridostigmine—Vomiting—Pamidronate—osteoporosis	0.000507	0.00122	CcSEcCtD
Pyridostigmine—Paraesthesia—Estradiol—osteoporosis	0.000504	0.00121	CcSEcCtD
Pyridostigmine—Asthenia—Conjugated Estrogens—osteoporosis	0.000503	0.00121	CcSEcCtD
Pyridostigmine—Rash—Pamidronate—osteoporosis	0.000503	0.00121	CcSEcCtD
Pyridostigmine—Dermatitis—Pamidronate—osteoporosis	0.000502	0.00121	CcSEcCtD
Pyridostigmine—Headache—Pamidronate—osteoporosis	0.000499	0.0012	CcSEcCtD
Pyridostigmine—Somnolence—Estradiol—osteoporosis	0.000499	0.0012	CcSEcCtD
Pyridostigmine—Diarrhoea—Zoledronate—osteoporosis	0.000498	0.0012	CcSEcCtD
Pyridostigmine—Nausea—Risedronate—osteoporosis	0.000498	0.0012	CcSEcCtD
Pyridostigmine—ACHE—Monoamine Transport—TNFRSF11B—osteoporosis	0.000494	0.0482	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00048	0.00116	CcSEcCtD
Pyridostigmine—Nausea—Pamidronate—osteoporosis	0.000474	0.00114	CcSEcCtD
Pyridostigmine—Vomiting—Zoledronate—osteoporosis	0.000463	0.00112	CcSEcCtD
Pyridostigmine—Feeling abnormal—Estradiol—osteoporosis	0.000462	0.00111	CcSEcCtD
Pyridostigmine—Rash—Zoledronate—osteoporosis	0.000459	0.00111	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Estradiol—osteoporosis	0.000459	0.00111	CcSEcCtD
Pyridostigmine—Dermatitis—Zoledronate—osteoporosis	0.000459	0.0011	CcSEcCtD
Pyridostigmine—Headache—Zoledronate—osteoporosis	0.000456	0.0011	CcSEcCtD
Pyridostigmine—Vomiting—Conjugated Estrogens—osteoporosis	0.000446	0.00107	CcSEcCtD
Pyridostigmine—Urticaria—Estradiol—osteoporosis	0.000446	0.00107	CcSEcCtD
Pyridostigmine—Abdominal pain—Estradiol—osteoporosis	0.000444	0.00107	CcSEcCtD
Pyridostigmine—Rash—Conjugated Estrogens—osteoporosis	0.000442	0.00106	CcSEcCtD
Pyridostigmine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000442	0.00106	CcSEcCtD
Pyridostigmine—Headache—Conjugated Estrogens—osteoporosis	0.000439	0.00106	CcSEcCtD
Pyridostigmine—Nausea—Zoledronate—osteoporosis	0.000433	0.00104	CcSEcCtD
Pyridostigmine—Nausea—Conjugated Estrogens—osteoporosis	0.000416	0.001	CcSEcCtD
Pyridostigmine—Hypersensitivity—Estradiol—osteoporosis	0.000413	0.000996	CcSEcCtD
Pyridostigmine—Asthenia—Estradiol—osteoporosis	0.000403	0.00097	CcSEcCtD
Pyridostigmine—Diarrhoea—Estradiol—osteoporosis	0.000384	0.000925	CcSEcCtD
Pyridostigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoporosis	0.000373	0.0365	CbGpPWpGaD
Pyridostigmine—Vomiting—Estradiol—osteoporosis	0.000357	0.000859	CcSEcCtD
Pyridostigmine—Rash—Estradiol—osteoporosis	0.000354	0.000852	CcSEcCtD
Pyridostigmine—Dermatitis—Estradiol—osteoporosis	0.000353	0.000851	CcSEcCtD
Pyridostigmine—Headache—Estradiol—osteoporosis	0.000352	0.000847	CcSEcCtD
Pyridostigmine—ACHE—Glycerophospholipid biosynthesis—MGLL—osteoporosis	0.000341	0.0333	CbGpPWpGaD
Pyridostigmine—Nausea—Estradiol—osteoporosis	0.000333	0.000803	CcSEcCtD
Pyridostigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoporosis	0.000333	0.0325	CbGpPWpGaD
Pyridostigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoporosis	0.000309	0.0301	CbGpPWpGaD
Pyridostigmine—BCHE—Glycerophospholipid biosynthesis—MGLL—osteoporosis	0.000304	0.0297	CbGpPWpGaD
Pyridostigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoporosis	0.000275	0.0269	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—REN—osteoporosis	0.000266	0.026	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—MGLL—osteoporosis	0.000238	0.0233	CbGpPWpGaD
Pyridostigmine—BCHE—Peptide hormone metabolism—REN—osteoporosis	0.000237	0.0232	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—MGLL—osteoporosis	0.000212	0.0207	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—ACE—osteoporosis	0.000166	0.0162	CbGpPWpGaD
Pyridostigmine—BCHE—Peptide hormone metabolism—ACE—osteoporosis	0.000148	0.0145	CbGpPWpGaD
Pyridostigmine—ACHE—Monoamine Transport—IL1B—osteoporosis	0.000143	0.014	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—ESR1—osteoporosis	0.000132	0.0129	CbGpPWpGaD
Pyridostigmine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000125	0.0122	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000119	0.0117	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000107	0.0104	CbGpPWpGaD
Pyridostigmine—ACHE—Monoamine Transport—TNF—osteoporosis	0.000104	0.0102	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—LEP—osteoporosis	0.000103	0.0101	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000101	0.00988	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	9.93e-05	0.00971	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	9.8e-05	0.00958	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.51e-05	0.0093	CbGpPWpGaD
Pyridostigmine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	9.36e-05	0.00915	CbGpPWpGaD
Pyridostigmine—BCHE—Peptide hormone metabolism—LEP—osteoporosis	9.19e-05	0.00898	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.02e-05	0.00881	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—POMC—osteoporosis	8.85e-05	0.00865	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CCT2—osteoporosis	8.74e-05	0.00854	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—IGF1—osteoporosis	8.51e-05	0.00832	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	8.49e-05	0.00829	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.05e-05	0.00787	CbGpPWpGaD
Pyridostigmine—BCHE—Peptide hormone metabolism—POMC—osteoporosis	7.9e-05	0.00771	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.86e-05	0.00768	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CCT2—osteoporosis	7.79e-05	0.00762	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.66e-05	0.00749	CbGpPWpGaD
Pyridostigmine—BCHE—Peptide hormone metabolism—IGF1—osteoporosis	7.59e-05	0.00742	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—TUBA1B—osteoporosis	7.43e-05	0.00726	CbGpPWpGaD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.19e-05	0.00702	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.01e-05	0.00685	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.84e-05	0.00668	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—TUBA1B—osteoporosis	6.63e-05	0.00648	CbGpPWpGaD
Pyridostigmine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	6.45e-05	0.00631	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.13e-05	0.00599	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.07e-05	0.00593	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—RPL24—osteoporosis	5.94e-05	0.0058	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.46e-05	0.00534	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.41e-05	0.00529	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—RPL24—osteoporosis	5.3e-05	0.00518	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—TLN1—osteoporosis	5.22e-05	0.0051	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.22e-05	0.0051	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.21e-05	0.00509	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—IL6—osteoporosis	5.15e-05	0.00503	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.15e-05	0.00503	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.15e-05	0.00503	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—REN—osteoporosis	5.02e-05	0.0049	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PKM—osteoporosis	4.75e-05	0.00464	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—FDPS—osteoporosis	4.75e-05	0.00464	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—TLN1—osteoporosis	4.66e-05	0.00455	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—ADCY5—osteoporosis	4.65e-05	0.00454	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.65e-05	0.00454	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GPD2—osteoporosis	4.5e-05	0.0044	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PGLS—osteoporosis	4.5e-05	0.0044	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—REN—osteoporosis	4.48e-05	0.00437	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.45e-05	0.00435	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.28e-05	0.00418	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—FDPS—osteoporosis	4.24e-05	0.00414	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PKM—osteoporosis	4.24e-05	0.00414	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.23e-05	0.00413	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.22e-05	0.00412	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—ADCY5—osteoporosis	4.15e-05	0.00405	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ATIC—osteoporosis	4.12e-05	0.00402	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PNP—osteoporosis	4.12e-05	0.00402	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PGLS—osteoporosis	4.02e-05	0.00392	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GPD2—osteoporosis	4.02e-05	0.00392	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ATIC—osteoporosis	3.67e-05	0.00359	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PNP—osteoporosis	3.67e-05	0.00359	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—OXCT1—osteoporosis	3.5e-05	0.00342	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CA2—osteoporosis	3.5e-05	0.00342	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—MGLL—osteoporosis	3.41e-05	0.00333	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.22e-05	0.00314	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.14e-05	0.00306	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—ACE—osteoporosis	3.13e-05	0.00306	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CA2—osteoporosis	3.12e-05	0.00305	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—OXCT1—osteoporosis	3.12e-05	0.00305	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—MGLL—osteoporosis	3.04e-05	0.00297	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—IDH2—osteoporosis	2.9e-05	0.00284	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.87e-05	0.0028	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—ACE—osteoporosis	2.79e-05	0.00273	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP27A1—osteoporosis	2.73e-05	0.00267	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.68e-05	0.00262	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.67e-05	0.00261	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ACP5—osteoporosis	2.65e-05	0.00259	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.62e-05	0.00256	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—IDH2—osteoporosis	2.59e-05	0.00253	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.54e-05	0.00248	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.49e-05	0.00244	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—TPI1—osteoporosis	2.47e-05	0.00241	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP27A1—osteoporosis	2.43e-05	0.00238	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ACP5—osteoporosis	2.37e-05	0.00231	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.34e-05	0.00228	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—P4HB—osteoporosis	2.32e-05	0.00227	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GAPDH—osteoporosis	2.28e-05	0.00222	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.25e-05	0.0022	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—RAP1A—osteoporosis	2.22e-05	0.00217	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.22e-05	0.00217	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—TPI1—osteoporosis	2.2e-05	0.00215	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—P4HB—osteoporosis	2.07e-05	0.00202	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GAPDH—osteoporosis	2.03e-05	0.00198	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—RAP1A—osteoporosis	1.98e-05	0.00193	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—LEP—osteoporosis	1.95e-05	0.0019	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.93e-05	0.00189	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ENO1—osteoporosis	1.79e-05	0.00175	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PSMA2—osteoporosis	1.77e-05	0.00173	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PSMA5—osteoporosis	1.77e-05	0.00173	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—LEP—osteoporosis	1.74e-05	0.0017	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.73e-05	0.00169	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—POMC—osteoporosis	1.67e-05	0.00163	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGF1—osteoporosis	1.61e-05	0.00157	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ENO1—osteoporosis	1.6e-05	0.00156	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PSMA2—osteoporosis	1.58e-05	0.00154	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PSMA5—osteoporosis	1.58e-05	0.00154	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—POMC—osteoporosis	1.49e-05	0.00146	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGF1—osteoporosis	1.43e-05	0.0014	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP19A1—osteoporosis	1.43e-05	0.0014	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.35e-05	0.00132	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP19A1—osteoporosis	1.28e-05	0.00125	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PKM—osteoporosis	1.27e-05	0.00124	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—FDPS—osteoporosis	1.27e-05	0.00124	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PGLS—osteoporosis	1.21e-05	0.00118	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GPD2—osteoporosis	1.21e-05	0.00118	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ADCY5—osteoporosis	1.17e-05	0.00114	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GPX1—osteoporosis	1.17e-05	0.00114	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ATIC—osteoporosis	1.1e-05	0.00108	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PNP—osteoporosis	1.1e-05	0.00108	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—MTHFR—osteoporosis	1.08e-05	0.00105	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ADCY5—osteoporosis	1.04e-05	0.00102	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GPX1—osteoporosis	1.04e-05	0.00102	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—MTHFR—osteoporosis	9.61e-06	0.000939	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CA2—osteoporosis	9.39e-06	0.000918	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—OXCT1—osteoporosis	9.39e-06	0.000918	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MGLL—osteoporosis	9.15e-06	0.000894	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—POMC—osteoporosis	8.61e-06	0.000842	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—IDH2—osteoporosis	7.78e-06	0.00076	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—POMC—osteoporosis	7.68e-06	0.000751	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP27A1—osteoporosis	7.32e-06	0.000715	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ACP5—osteoporosis	7.12e-06	0.000695	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TPI1—osteoporosis	6.62e-06	0.000646	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—P4HB—osteoporosis	6.22e-06	0.000608	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GAPDH—osteoporosis	6.11e-06	0.000597	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—RAP1A—osteoporosis	5.95e-06	0.000581	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ENO1—osteoporosis	4.81e-06	0.00047	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PSMA2—osteoporosis	4.74e-06	0.000463	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PSMA5—osteoporosis	4.74e-06	0.000463	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.84e-06	0.000376	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.14e-06	0.000307	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GPX1—osteoporosis	3.13e-06	0.000306	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MTHFR—osteoporosis	2.89e-06	0.000282	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—POMC—osteoporosis	2.31e-06	0.000226	CbGpPWpGaD
